Outlook Therapeutics (OTLK) Return on Invested Capital [ROIC] (2016 - 2025)
Outlook Therapeutics (OTLK) recorded Return on Invested Capital [ROIC] of -529.39% in fiscal Q4 2025 (quarter ended Sep 30, 2025).
Powered by 
Analysis
Outlook Therapeutics (OTLK) Return on Invested Capital [ROIC] (2016 - 2025) Analysis & Trends
For FY2023 (ended Sep 30, 2023), Outlook Therapeutics reported Return on Invested Capital [ROIC] of -260.65%, up 89.27 percentage points from FY2022.
- Annual Return on Invested Capital [ROIC] has increased for three straight fiscal years, with a three-year change of +2281.76 percentage points (FY2020 to FY2023).
- Across earlier fiscal years, Return on Invested Capital [ROIC] came in at -349.92% in FY2022 (+84.93 pp), -434.85% in FY2021 (+2107.56 pp) and -2542.41% in FY2020.
- The fiscal Q4 2025 figure is the highest quarterly Return on Invested Capital [ROIC] since fiscal Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 30.89% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.57% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 24.28% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.52% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 23.11% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 15.60% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.11% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 12.34% |
| 10 | Outlook Therapeutics | 62.90 Mn | 27.15 Mn | -8,265.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -529.39% |
| Sep 30, 2023 | -211.06% |
| Jun 30, 2023 | -152.79% |
| Mar 31, 2023 | -119.12% |
| Sep 30, 2022 | -251.31% |
| Jun 30, 2022 | -140.04% |
| Mar 31, 2022 | -87.72% |
| Sep 30, 2021 | -278.97% |
| Jun 30, 2021 | -160.38% |
| Mar 31, 2021 | -258.64% |
| Sep 30, 2020 | -251.27% |
| Sep 30, 2019 | -103,049.78% |
| Sep 30, 2016 | -1,476.74% |
API Access
Outlook Therapeutics Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();